INES VILORIA: Open Payments
NPI 1023554227 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 26 payments from 11 companies in 2025. Trend: 2023 $729 · 2024 $593 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 11 | $248 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| ABBVIE INC. | 2 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Alkermes, Inc. | 1 | $24 |
| Bausch Health US, LLC | 1 | $23 |
| Lundbeck LLC | 1 | $20 |
| ACADIA Pharmaceuticals Inc | 1 | $19 |
Products named: Azstarys, Auvelity, CAPLYTA, Qelbree, TRINTELLIX, VRAYLAR, LYBALVI, SYNTHROID.
Industry payments across FL — which companies pay providers there.
